Association between EEG abnormalities and csf biomarkers in a memory clinic cohort

Dementia and Geriatric Cognitive Disorders

Volumn 36, Issue 5-6, 2013, Pages 319-328

  Kramberger, Milica Gregoric ^a,b,h   Kåreholt, Ingemar ^c,d,g   Andersson, Thomas ^e   Winblad, Bengt ^a,b   Eriksdotter, Maria ^a,b,c,f   Jelic, Vesna ^a,b,c,f  

^a Department of Neurobiology Care Sciences and Society ^*  (Sweden)

^b Alzheimer Research Centre   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e Departments of Clinical Neurophysiology   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g JÖNKÖPING UNIVERSITY   (Sweden)

^h UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Alzheimer's disease; Biomarkers; Cerebrospinal fluid; Electroencephalography; Mild cognitive impairment

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; LITHIUM; NEUROLEPTIC AGENT; TAU PROTEIN; GLUCOSE; PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; DEMENTIA; EEG ABNORMALITY; FEMALE; HOSPITAL; HUMAN; MALE; MENTAL DISEASE; NERVE DEGENERATION; NEUROIMAGING; PHENOTYPE; PRIORITY JOURNAL; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; ELECTROENCEPHALOGRAM; FRONTOTEMPORAL DEMENTIA; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PROTEIN PHOSPHORYLATION;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; COHORT STUDIES; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MODELS, STATISTICAL; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84890531575     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000351677     Document Type: Article

References (41)

1. Andersson C, Lindau M, Almkvist O, Engfeldt P, Johansson SE, Eriksdotter Jönhagen M: Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients. Dement Geriatr Cogn Disord 2006; 21: 251-259
2. Bouwman FH, Schoonenboom SN, van der Flier WM, van Elk EJ, Kok A, Barkhof F, Blankenstein MA, Scheltens P: CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neuro - biol Aging 2007; 28: 1070-1074 (Pubitemid 46635910)
3. De Leon MJ, Mosconi L, Blenow K, DeSanti S, Zinkovski R, Mehta PD, Pratico D, Tsui W, Saint Louis LA, Sobanska L, Brys M, Li Y, Rich K, Rinne J, Rusinek H: Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann NY Acad Sci 2007; 1097: 114-145 (Pubitemid 47084889)
4. Dubois B, Feldman HH, Jacova C DeKosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Menguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746 (Pubitemid 47058377)
5. Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P: Revising the definition of Alzheimer's disease: a new lexicon. Lancet 2010; 9: 118-127
6. Gauthier S, Patterson C, Gordon M, Soucy JP, Schubert F, Leuzy A: Commentary on 'Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease'. A Canadian perspective. Alzheimer Dementia 2011; 7: 330-332
7. Nuwer M: Assessment of digital EEG, quantitative EEG, and EEG brain mapping: report of the American Academy of Neurology and the American Clinical Neurophysiological Society. Neurology 1997; 49: 277-292 (Pubitemid 27328721)
8. Jelic V, Kowalski J: Evidence-based evaluation of diagnostic accuracy of resting EEG in dementia and mild cognitive impairment. Clin EEG Neurosci 2009; 40: 129-142
9. Coben LA, Danziger W, Storandt M: A longitudinal EEG study of mild senile dementia of Alzheimer type: changes at 1 year and at 2.5 years. Electroencephalogr Clin Neurophysiol 1985; 61: 101-112 (Pubitemid 16218363)
10. Soininen H, Partanen J, Laulumaa V, Helkala EL, Laakso M, Riekkinen PJ: Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. Electroencephalogr Clin Neurophysiol 1989; 72: 290-297 (Pubitemid 19085665)
11. Hooijer C, Jonker C, Posthuma J, Visser SL: Reliability, validity and follow-up of the EEG in senile dementia: sequelae of sequential measurement. Electroencephalogr Clin Neurophysiol 1990; 76: 400-412 (Pubitemid 20370123)
12. Duffy FH, McAnulty GB, Albert MS: Temporoparietal electrophysiological differences characterize patients with Alzheimer's disease: a split-half replication study. Cereb Cortex 1995; 5: 215-221
13. Jelic V, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO: Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. Dementia 1996; 7: 314-323 (Pubitemid 26341260)
14. Claus JJ, Kwa VIH, Teunisse S: Slowing on quantitative spectral EEG is a marker for rate of subsequent cognitive and functional decline in early Alzheimer disease. Alzheimer Dis Assoc Disorder 1998; 12: 167-174 (Pubitemid 29154985)
15. Huang C, Wahlund LO, Dierks T: Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin Neurophysiol 2000; 111: 1961-1967
16. Babiloni C, Ferri R, Moretti DV: Abnormal fronto-parietal coupling of brain rhythms in mild Alzheimer's disease: a multicentric EEG study. Eur J Neurosci 2004; 19: 2583-2590 (Pubitemid 38621856)
17. Koenig T, Prichep L, Dierks T, Hubl D, Wahlund LO, John ER, Jelic V: Decreased EEG synchronisation in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 2005; 26: 165-171 (Pubitemid 39610461)
18. Prichep LS, John ER, Ferris SH, Rausch L, Fang Z, Cancro R, Torossian C, Reisberg B: Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. Neurobiol Aging 2006; 27: 471-481 (Pubitemid 43185333)
19. Dierks T, Jelic V, Pascual-Marqui RD, Wahlund L, Julin P, Linden DE, Maurer K, Winblad B, Nordberg A: Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clin Neurophysiol 2000; 11: 1817-1824
20. Van der Hiele K, Vein AA, Reijntjes RHAM, Westendorp RG, Bollen EL, van Buchem MA, van Dijk JG, Middelkoop HA: EEG correlates in the spectrum of cognitive decline. Clin Neurophysiol 2007; 118: 1931-1939 (Pubitemid 47187761)
21. Claus JJ, Ongerboer de Visser BW, Bour LJ, Walstra GJ, Hijdra A, Verbeeten B Jr, Van Royen EA, Kwa VI, van Gool WA: Determinants of quantitative spectral electroencephalography in early Alzheimer's disease: cognitive functioning, regional cerebral blood flow, and computed tomography. Dement Geriatr Cogn Disord 2000; 11: 81-89 (Pubitemid 30114089)
22. Dierks T, Frölich L, Ihl R, Maurer K: Correlation between cognitive brain function and electrical brain activity in dementia of Alzheimer type. J Neural Transm Gen Sect 1995; 99: 55-62
23. Jelic V, Blomberg M, Dierks T, Basun H, Shigeta M, Julin P, Jensen M, Lannfelt L, Winblad B, Wahlund LO: EEG slowing and cerebrospinal fluid tau levels in patients with cognitive decline. Neuroreport 1998; 9: 157-160 (Pubitemid 28046674)
24. Stomrud E, Hansson O, Minthon L, Blennow K, Rosen I, Londos E: Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years. Neurobiol Aging 2010; 31: 215-223
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944 (Pubitemid 14076461)
26. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246 (Pubitemid 39222993)
27. Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K: Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem 2005; 51: 336-345 (Pubitemid 40175803)
28. Jonker C, Geerlings MI, Schmand B: Are memory complaints predicitive of dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry 2000; 15: 983-991
29. Visser PJ, Kester A, Jolles J, Verhey F: Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006; 67: 1201-1207 (Pubitemid 44563828)
30. Andreasen N, Blenow K: CSF-biomarkers for mild cognitive impairment and early Alzheimer's disease. Clin Neurol Neurosurg 2005; 107: 165-173
31. Rodriguez G, Arnaldi D, Picco A: Brain functional network in Alzheimer's disease: diagnostic markers for diagnosis and monitoring. Int J Alzheimers Dis 2011; 2011: 481903
32. Rae-Grant A, Blume W, Lau C, Hachinski VC, Fisman M, Merskey H: The electroencephalogram in Alzheimertype dementia. A sequential study correlating the electroencephalogram with psychometric and quantitative pathologic data. Arch Neurol 1987; 44: 50-54 (Pubitemid 17087612)
33. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC: Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer's disease. Arch Neurol 2001; 58: 1395-1402 (Pubitemid 32845990)
34. Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH: Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 257-262
35. Liedorp M, van der Flier WM, Hoogervorst ELJ, Scheltens P, Stam CJ: Associations between patterns of EEG abnormalities and diagnosis in a large memory clinic cohort. Dement Geriatr Cogn Disord 2009; 27: 18-23
36. Robinson DJ, Merskey H, Blume WT, Fry R, Williamson PC, Hachinski VC: Electroencephalography as an aid in the exclusion of Alzheimer's disease. Arch Neurol 1994; 51: 280-284 (Pubitemid 24088415)
37. Snyder MS, Hall JR, Cornwell SL, Falk JD: Addition of EEG improves accuracy of a logistic model that uses neuropsychological and cardiovascular factors to identify dementia and MCI. Psychiatry Res 2011; 186: 97-102
38. Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K: Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann NY Acad Sci 2000; 903: 411-423 (Pubitemid 30251583)
39. De la Torre JC: Is Alzheimer's disease neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3: 184-190 (Pubitemid 38232669)
40. Smits LL, Liedorp M, Koene T, Roos-Reuling IE, Lemstra AW, Scheltens P, Stam CJ, van der Flier WM: EEG abnormalities are associated with different cognitive profiles in Alzheimer's disease. Dement Geriatr Cogn Disord 2011; 31: 1-6
41. De Waal H, Stam CJ, Blankenstein MA, Pijnenburg YA, Scheltens P, van der Flier WM: EEG abnormalities in early and late onset Alzheimer's disease: understanding heterogeneity. J Neurol Neurosurg Psychiatry 2011; 82: 67-71.